Drugs / RTV
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT01907724 | May → Aug 2013 | chronic hepatitis C virus infection | Merck Sharp & Dohme LLC | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | RTV | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01907724 ↗ |
| Route | Oral | “RTV will be supplied as 80 mg/mL solution for oral administration.” NCT01907724 ↗ |